Advertisement

Topics

Quite A Range: Adamas Ponders $10,000-$30,000 Price Tag For Gocovri

20:28 EDT 24 Aug 2017 | SCRIP

The US FDA approved the extended-release amantadine for levodopa-induced dyskinesia in Parkinson's disease. Adamas will finalize its pricing and begin...

      

Related Stories

 

Original Article: Quite A Range: Adamas Ponders $10,000-$30,000 Price Tag For Gocovri

NEXT ARTICLE

More From BioPortfolio on "Quite A Range: Adamas Ponders $10,000-$30,000 Price Tag For Gocovri"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...